Literature DB >> 6191048

Treatment of advanced renal cell carcinoma--traditional methods and innovative approaches.

J B deKernion.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6191048     DOI: 10.1016/s0022-5347(17)50926-x

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  11 in total

1.  Initial experience with arterial spin-labeling MR imaging to assess histology of renal masses.

Authors:  Venkat Masarapu; Hyung L Kim
Journal:  Quant Imaging Med Surg       Date:  2013-06

2.  Regression of pulmonary metastases with long term remission in a patient with renal carcinoma.

Authors:  M M Rahima; J Barzilay
Journal:  Thorax       Date:  1985-03       Impact factor: 9.139

3.  Local recurrence of renal cell carcinoma after partial nephrectomy: applicability of the apparent diffusion coefficient of MRI as an imaging marker - a multicentre study.

Authors:  Yulian Mytsyk; Andriy Borzhiyevskyy; Ihor Dutka; Alexander Shulyak; Paweł Kowal; Dmytro Vorobets; Michał Skrzypczyk; Oleksandr Borzhiyevs'kyy; Andrzej Górecki; Viktoria Matskevych
Journal:  Pol J Radiol       Date:  2022-06-15

4.  Immunoscintigraphic localization of renal tumours in an extracorporeal perfusion model with a monoclonal antibody against gamma-glutamyltransferase.

Authors:  P Fischer; R P Baum; M Tauber; W Boeckmann; S Weier; J E Scherberich
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

5.  Metastatic renal cell carcinoma (RCC): spontaneous regression, long-term survival and late recurrence.

Authors:  W de Riese; K Goldenberg; E Allhoff; C Stief; R Schlick; S Liedke; U Jonas
Journal:  Int Urol Nephrol       Date:  1991       Impact factor: 2.370

6.  Adjuvant chemotherapy with vinblastine, adriamycin, and UFT for renal-cell carcinoma.

Authors:  F Masuda; J Nakada; I Kondo; N Furuta
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

7.  A phase II trial of interferon alpha-2A plus fluorouracil in advanced renal cell carcinoma. A Hoosier Oncology Group study.

Authors:  B R Murphy; S M Rynard; L H Einhorn; P J Loehrer
Journal:  Invest New Drugs       Date:  1992-08       Impact factor: 3.850

8.  Prolonged survival following palliative renal tumor embolization by capillary occlusion.

Authors:  G W Kauffmann; G M Richter; R Rohrbach; W Wenz
Journal:  Cardiovasc Intervent Radiol       Date:  1989 Jan-Feb       Impact factor: 2.740

9.  Percutaneous transluminal embolization for improved prognosis of renal cell carcinoma--dependence on tumor stages.

Authors:  F Stoesslein; A Schwenke; W Muenster
Journal:  Cardiovasc Intervent Radiol       Date:  1988-04       Impact factor: 2.740

10.  A phase II study of vinblastine in combination with acrivastine in patients with advanced renal cell carcinoma.

Authors:  J Berlin; A C King; K Tutsch; J W Findlay; P Kohler; M Collier; N J Clendeninn; G Wilding
Journal:  Invest New Drugs       Date:  1994       Impact factor: 3.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.